Xtx Topco LTD Replimune Group, Inc. Transaction History
Xtx Topco LTD
- $1.12 Billion
- Q2 2024
A detailed history of Xtx Topco LTD transactions in Replimune Group, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 14,505 shares of REPL stock, worth $167,677. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,505
Previous 17,675
17.93%
Holding current value
$167,677
Previous $144,000
9.72%
% of portfolio
0.01%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding REPL
# of Institutions
154Shares Held
70MCall Options Held
26.7KPut Options Held
28.6K-
Baker Bros. Advisors LP New York, NY10MShares$116 Million1.2% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD9.24MShares$107 Million0.01% of portfolio
-
Redmile Group, LLC San Francisco, CA5.56MShares$64.3 Million3.26% of portfolio
-
Fcpm Iii Services B.V. Naarden, P74.87MShares$56.3 Million6.46% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$54.5 Million0.0% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $570M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...